These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 22430596)
21. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. Kaplan SA; Te AE; Pressler LB; Olsson CA J Urol; 1995 Nov; 154(5):1764-9. PubMed ID: 7563342 [TBL] [Abstract][Full Text] [Related]
22. [Volumes of total prostate and transitional zone are positively correlated with age in benign prostatic hyperplasia patients]. Liu ZY; Xu CL; Gao X; Zhang LM; Gao XF; Zhang ZS; Zhou T; Sun YH Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1103-5. PubMed ID: 19157231 [TBL] [Abstract][Full Text] [Related]
23. Does digital rectal examination predict prostate volume greater than 30 mL? Yamamoto T; Fukuta F; Masumori N Int J Urol; 2017 May; 24(5):373-376. PubMed ID: 28294421 [TBL] [Abstract][Full Text] [Related]
24. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases. Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706 [TBL] [Abstract][Full Text] [Related]
25. Structural Variation of Prostate Urethra Reflected by the Ratio Between Prostate Volume and Prostatic Urethral Length is Associated with the Degrees of Lower Urinary Tract Symptoms. Ko YH; Song PH Low Urin Tract Symptoms; 2016 May; 8(2):113-9. PubMed ID: 27111623 [TBL] [Abstract][Full Text] [Related]
26. The importance of the prostate weight in transurethral microwave thermotherapy. Netto Júnior NR; de Lima ML; Claro Jde A; de Andrade EF Arch Esp Urol; 1995 May; 48(4):413-7. PubMed ID: 7541194 [TBL] [Abstract][Full Text] [Related]
27. Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men? Otunctemur A; Ozbek E; Besiroglu H; Dursun M; Sahin S; Koklu I; Erkoc M; Danis E; Bozkurt M; Gurbuz A Int J Urol; 2014 Dec; 21(12):1268-72. PubMed ID: 25056570 [TBL] [Abstract][Full Text] [Related]
28. Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia. Zhang W; Zheng X; Wang Y; Xiao H Urology; 2016 Nov; 97():212-218. PubMed ID: 27327576 [TBL] [Abstract][Full Text] [Related]
29. Visceral adiposity index is associated with benign prostatic enlargement in non-diabetic patients: a cross-sectional study. Besiroglu H; Ozbek E; Dursun M; Otunctemur A Aging Male; 2018 Mar; 21(1):40-47. PubMed ID: 28823197 [TBL] [Abstract][Full Text] [Related]
30. [Correlation between prostatic parameters of transrectal ultrasonography and age in patients with benign prostatic hyperplasia]. Cao NL; Lu QJ; Wang XH; Ni JS; Gu BJ; Hu B Zhonghua Nan Ke Xue; 2017 Apr; 23(4):315-318. PubMed ID: 29714415 [TBL] [Abstract][Full Text] [Related]
32. Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine. Hedelin H; Johansson N; Ströberg P Scand J Urol Nephrol; 2005; 39(2):154-9. PubMed ID: 16019770 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial. Sengupta G; Hazra A; Kundu A; Ghosh A Clin Ther; 2011 Dec; 33(12):1943-52. PubMed ID: 22177370 [TBL] [Abstract][Full Text] [Related]
34. Genetic alterations in benign prostatic hyperplasia patients. Mohamed HM; Aly MS; Hussein TD Ger Med Sci; 2017; 15():Doc16. PubMed ID: 29234244 [No Abstract] [Full Text] [Related]
35. Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume. Fowke JH; Phillips S; Koyama T; Byerly S; Concepcion R; Motley SS; Clark PE BJU Int; 2013 Jan; 111(1):122-8. PubMed ID: 22726636 [TBL] [Abstract][Full Text] [Related]
36. Occlusion of the Internal Iliac Artery Is Associated with Smaller Prostate and Decreased Urinary Tract Symptoms. Deipolyi AR; Al-Ansari S; Khademhosseini A; Oklu R J Vasc Interv Radiol; 2015 Sep; 26(9):1305-10. PubMed ID: 26065926 [TBL] [Abstract][Full Text] [Related]
37. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial. Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428 [TBL] [Abstract][Full Text] [Related]
38. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms]. Park SC; Lee JW; Rim JS Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947 [TBL] [Abstract][Full Text] [Related]
39. The correlation between prostate-specific antigen and age. Analysis of prostate-specific antigen values from 4,846 Turkish men with symptomatic benign prostatic hyperplasia. Uygur MC; Erol D; Cetinkaya M; Güngen Y; Laleli Y; Altuğ U Eur Urol; 1997; 32(4):416-9. PubMed ID: 9412798 [TBL] [Abstract][Full Text] [Related]
40. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. Grossfeld GD; Coakley FV Radiol Clin North Am; 2000 Jan; 38(1):31-47. PubMed ID: 10664665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]